Task: Answer the multiple-choice question.
Question: Which drug exhibits a 0.361% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a.) CC(C)(C)N1CC(C(=O)Nc2ccc(S(=O)(=O)N3CCCCC3)cc2)CC1=O
b.) CCOC(=O)c1[nH]c2ccc(F)cc2c1NC(=O)CN1CCc2cc(OC)c(OC)cc2C1
Answer: a. CC(C)(C)N1CC(C(=O)Nc2ccc(S(=O)(=O)N3CCCCC3)cc2)CC1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)(C)N1CC(C(=O)Nc2ccc(S(=O)(=O)N3CCCCC3)cc2)CC1=O
CC(C)(C)N1CC(C(=O)Nc2ccc(S(=O)(=O)N3CCCCC3)cc2)CC1=O
1-tert-butyl-5-oxo-N-(4-piperidin-1-ylsulfonylphenyl)pyrrolidine-3-carboxamide